CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	3 Months Ended		73 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (418,577)	$ (163,611)	$ (6,267,483)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	8,496	8,125	176,693
Allowance for uncollectible notes receivable			38,867
Amortization of debt discount	15,345		17,565
Amortization of deferred finance costs			59,606
Interest (income) expense on fair value adjustment on convertible notes payable	(80,609)	(28,670)	369,744
Interest accrued on note receivable			(11,705)
Write-off of uncollectible deposit			20,000
Loss on extinguishment of debt			381,113
Loss on impairment			42,800
Stock issued for services	690,180	7,901	2,524,036
Stock issued to satisfy legal services	51,199		116,693
Stock issued for financing fees			5,000
Changes in operating assets and liabilities:
Prepaid expenses	(426,160)	29,975	(474,420)
Advances to shareholders		(1,001)	(1,015)
Deposits and other receivables			(23,346)
Accounts payable and accrued liabilities	(8,358)	(2,741)	223,843
Net cash used in operating activities	(168,484)	(150,022)	(2,802,009)
CASH FLOWS FROM INVESTING ACTIVITIES
Issuance of notes receivable			(25,000)
Purchase of investment in LLC		(12,000)	(34,100)
Acquisition of equipment			(325,000)
Net cash used in investing activities		(12,000)	(384,100)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the issuance of common stock	151,845	80,000	2,199,389
Proceeds from the issuance of convertible notes, related parties	55,500	50,000	111,500
Proceeds from the issuance of convertible notes, non related parties	79,000	40,000	841,800
Proceeds from the issuance of notes payable			286,500
Proceeds from the issuance of notes payable - related parties			8,500
Payments on convertible notes payable	(30,000)		(76,000)
Payments on notes payable			(57,500)
Payments on notes payable - related parties			(1,000)
Proceeds from loans from stockholders			40,925
Payments on loans from stockholder loans			(36,225)
Net cash provided by financing activities	256,345	170,000	3,317,889
NET INCREASE IN CASH	87,861	7,978	131,780
CASH, BEGINNING OF PERIOD	43,919	8,838
CASH, ENDING OF PERIOD	131,780	16,816	131,780
NONCASH OPERATING AND FINANCING ACTIVITIES:
Due to Organetix, Inc. reclassified to additional paid-in capital			91,500
Common stock issued in conjunction with a joint venture			9,800
Common stock issued to satisfy debt			76,528
Common stock issued to satisfy minimum value guarantee			87,667
Convertible debt converted to common stock including accrued interest			1,238,248
Common stock issued in exchange for a fixed asset			7,400
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest			$ 3,660